2025 Annual Meeting

SATELLITE SYMPOSIA


The Canadian Society of Otolaryngology – Head & Neck Surgery extends sincere thanks to our valued corporate sponsors for their incredible support of the 79th Annual Meeting through a series of engaging and informative presentations.

We invite all attendees to participate — each session you attend contributes to your progress in the 2025 Interactive Passport Program, where you’ll have the chance to win exciting prizes, including a trip for two to the Azores.

Explore the sponsor sessions, earn points, and make the most of your conference experience!

LEARN MORE ABOUT THE PASSPORT PROGRAM

FRIDAY, MAY 30TH

50 POINTS

Practice Changing Updates in Resectable LA HNSCC Treatment Landscape

BROUGHT TO YOU BY MERCK

  • MARYSVILLE A
  • FRIDAY, MAY 30TH
  • 12:00 PM

DESCRIPTION

In this symposia, Dr Martin Smoragiewicz a medical oncologist of Kingston Health Sciences Centre and assistant professor at Queen’s University will present practice changing treatment updates for LA HNSCC from the 2025 American Associate Cancer Research congress. Joining him, Dr Kevin Higgins, an otolaryngologist of Sunnybrook Health Sciences Centre, will discuss his surgical experiences with neoadjuvant-adjuvant immunotherapy and a patient case he wishes to share. This symposia will be moderated and discussed by Dr James Michael, a medical oncologist of Saint John Regional Hospital.

OBJECTIVES

  • Review major updates from AACR 2025 in LA HNSCC
  • Discuss medical and surgical approaches to neoadjuvant-adjuvant immunotherapy in HNSCC
  • Discuss impact and barriers of recent data in clinical practice

SPEAKERS: Kevin Higgins MSc, MD, FACS, FRCSC, University of Toronto, Martin Smoragiewicz, MD, PhD, Queen’s University

MODERATOR: James Michael, MD, FRCSC, Dalhousie University

Saturday, MAY 31st

25 POINTS

Progressive Techniques in Paediatric Tonsillectomy:

COBLATION · Intracapsular Tonsillectomy Experience

BROUGHT TO YOU BY SMITH & NEPHEW / SOUTH MEDIC

  • exhibits hall
  • SATURDAY, MAY 31ST
  • 9:45 AM (COFFEE BREAK)

OBJECTIVES

    • Identify the use of COBLATION technology in ENT surgery, including latest evidence 
    • Differentiate COBLATION Intracapsular Tonsillectomy from other techniques

SPEAKER: Kiersten Pianosi, MD, FRSCS, University of British Columbia, BC Children’s Hospital

50 POINTS

Keepin' it real:

Sharing new real-world data on the evolving management of CRSwNP

BROUGHT TO YOU BY SANOFI REGENERON

  • exhibits hall
  • SATURDAY, MAY 31ST
  • 11:55 AM (LUNCH HOUR)

OBJECTIVES

  • Discuss the impact for real world evidence on the management of CRSwNP in Canadian practice
  • Review the latest evidence from real-world effectiveness studies for olfaction, long term outcomes and the use of biologics in patients with CRSwNP
  • Apply learnings from data presented in real world evidence to clinical case examples

SPEAKERS: Andrew Thamboo, MD, FRCSC, MHSc, University of British Columbia, Vancouver, BC; Leigh Sowerby, MD, MHM, FRCSC, Western University, London, ON

MODERATOR: Nathalie Gabra, MD, MSc, FRCSC, FACS, McGill University, Montreal, QC

Sunday, JUNE 1ST

50 POINTS

from reduction to restoration:

rethinking crsWNP MANAGEMENT

BROUGHT TO YOU BY ASTRAZENECA

  • exhibits hall
  • SUNDAY, JUNE 1ST
  • 7:30 am (BREAKFAST)

OBJECTIVES

  • Discuss the evolution of strategies to conserve epithelial integrity and changing the approach to epithelial health restoration
  • Discuss the emerging evidence in CRSwNP and novel treatment options
  • Present and discuss patient cases that showcase the patient spectrum from surgical management to medical management

SPEAKERS: Andrew Thamboo, MD, FRCSC, MHSc, University of British Columbia, Vancouver, BC; Leigh Sowerby, MD, MHM, FRCSC, Western University, London, ON; Richard Gall, MD, FRCSC, University of Manitoba, Winnipeg, MB

25 POINTS

Resectability of advanced Cutaneous Squamous Cell Carcinomas (CSCC) and future directions

BROUGHT TO YOU BY REGENERON

  • exhibits hall
  • SUNDAY, JUNE 1ST
  • 10:15 am (COFFEE BREAK)

OBJECTIVES

  • Identify key clinical and pathological factors that influence the resectability of advanced CSCC.

    • Evaluate the role of systemic therapy in the management of advanced and unresectable CSCC.
    • Discuss emerging treatment options and evolving strategies for managing resectable CSCC.

SPEAKER: Kevin Higgins MSc, MD, FACS, FRCSC, University of Toronto,

MODERATOR: Martin Smoragiewicz, MD, PhD, Queen’s University

50 POINTS

Optimizing Care in CRSwNP:

mANAGING crsWnp with ease (e's): early intervention, effective treatments, ensuring safety, epithelial impact

BROUGHT TO YOU BY GSK

  • exhibits hall
  • SUNDAY, JUNE 1ST
  • 11:35 AM

OBJECTIVES

• Identify strategies for early intervention in the T2 CRSwNP patient to optimize outcomes

• Evaluate comprehensive approaches to surgical intervention

• Discuss safety and monitoring for appropriate biologics use

• Examine the pleiotropic role of IL-5 and impact on patient outcomes

SPEAKERS: Yvonne Chan, MD, FRCSC,University of Toronto, Toronto, ON ; Doron Sommer, MD, FRCSC, McMaster University, Hamilton, ON ; Daniel Lee, MD, FRCSC, University of Toronto, Toronto, ON ; Andrew Thamboo, MD, FRCSC, University of British Columbia, Vancouver, BC